JANUVIA 50 mg, film-coated tablet 50 tablets
Active ingredients: Sitagliptin phosphate hydrate, Sitagliptin
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet50 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JANUVIA 50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 50 plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 1 comprimé(s)
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Jun 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60595727CIP75707106CIP133400957071066Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SITAGLIPTINEcomprimé | 50 mg · un comprimé | FT |
| PHOSPHATE DE SITAGLIPTINE MONOHYDRATÉcomprimé | 64,25 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: SITAGLIPTINE (PHOSPHATE DE) MONOHYDRATE équivalant à SITAGLIPTINE 50 mg - SITAGLIPTINE (MALATE DE) équivalant à SITAGLIPTINE 50 mg - JANUVIA 50 mg, comprimé pelliculé
